EXAS [NASD]
Exact Sciences Corporation
Index- P/E- EPS (ttm)-4.32 Insider Own0.80% Shs Outstand174.42M Perf Week7.88%
Market Cap8.44B Forward P/E- EPS next Y-3.12 Insider Trans-7.49% Shs Float174.39M Perf Month-24.62%
Income-745.40M PEG- EPS next Q-1.06 Inst Own93.00% Short Float7.79% Perf Quarter-33.66%
Sales1.85B P/S4.56 EPS this Y36.20% Inst Trans4.30% Short Ratio6.55 Perf Half Y-43.16%
Book/sh18.68 P/B2.78 EPS next Y-10.60% ROA-11.20% Target Price99.44 Perf Year-46.31%
Cash/sh5.03 P/C10.34 EPS next 5Y- ROE-21.80% 52W Range46.15 - 133.99 Perf YTD-33.19%
Dividend- P/FCF- EPS past 5Y-16.30% ROI-10.90% 52W High-59.62% Beta1.26
Dividend %- Quick Ratio2.30 Sales past 5Y77.80% Gross Margin73.90% 52W Low17.23% ATR4.19
Employees6420 Current Ratio2.50 Sales Q/Q21.00% Oper. Margin-39.50% RSI (14)45.14 Volatility7.34% 7.82%
OptionableYes Debt/Eq0.68 EPS Q/Q-464.00% Profit Margin-40.30% Rel Volume1.02 Prev Close52.00
ShortableYes LT Debt/Eq0.67 EarningsApr 26 AMC Payout- Avg Volume2.07M Price54.10
Recom1.60 SMA20-2.46% SMA50-13.80% SMA200-33.63% Volume1,896,941 Change4.04%
Nov-03-21Downgrade Raymond James Strong Buy → Outperform $160 → $130
Jul-29-21Reiterated Stifel Buy $165 → $145
Jul-29-21Reiterated Oppenheimer Outperform $161 → $155
Jul-29-21Reiterated Canaccord Genuity Buy $185 → $160
Jul-29-21Reiterated BTIG Research Buy $155 → $145
Jun-15-21Initiated Raymond James Strong Buy $160
Jun-03-21Initiated Goldman Buy $160
May-25-21Initiated Wells Fargo Equal Weight $115
Jan-28-21Initiated Truist Buy $226
Oct-29-20Downgrade UBS Buy → Neutral $125 → $140
Oct-28-20Downgrade Citigroup Buy → Neutral $120 → $140
Oct-08-20Resumed BTIG Research Buy $140
Apr-02-20Initiated Evercore ISI Outperform $70
Jan-10-20Resumed BTIG Research Buy $127
Jan-07-20Initiated Citigroup Buy $120
Dec-13-19Initiated Dougherty & Company Buy $120
Nov-15-19Initiated Stifel Buy
Oct-17-19Reiterated BofA/Merrill Buy $130 → $135
Oct-01-19Resumed Craig Hallum Buy $127
Sep-26-19Initiated Oppenheimer Outperform $130
May-06-22 10:58AM  
May-03-22 10:39AM  
May-02-22 06:00AM  
Apr-28-22 09:00AM  
Apr-27-22 10:25AM  
09:54AM  
09:41AM  
12:30AM  
Apr-26-22 06:05PM  
Apr-22-22 02:15AM  
Apr-08-22 06:00AM  
Apr-07-22 10:30AM  
Mar-31-22 08:54AM  
Mar-30-22 06:15PM  
Mar-24-22 11:30AM  
Mar-15-22 06:15PM  
11:34AM  
Mar-09-22 06:15PM  
Mar-07-22 09:00AM  
Mar-01-22 08:30AM  
Feb-28-22 06:00AM  
Feb-24-22 02:15PM  
10:45AM  
Feb-23-22 09:38AM  
07:53AM  
Feb-22-22 06:05PM  
04:05PM  
Feb-21-22 09:30AM  
Feb-18-22 06:15PM  
Feb-16-22 09:37AM  
Feb-10-22 11:55AM  
Feb-09-22 09:59AM  
Feb-08-22 06:15PM  
03:00PM  
06:00AM  
Feb-03-22 11:20AM  
09:38AM  
Feb-02-22 01:38PM  
03:52AM  
Feb-01-22 06:15PM  
06:00AM  
Jan-31-22 01:38PM  
Jan-26-22 06:15PM  
05:38PM  
05:38PM  
05:38PM  
05:38PM  
Jan-25-22 11:00AM  
Jan-24-22 05:38PM  
Jan-18-22 05:01PM  
01:38PM  
Jan-12-22 10:45AM  
Jan-09-22 07:00PM  
07:00PM  
07:00PM  
Jan-07-22 06:15PM  
Jan-06-22 05:38PM  
Jan-03-22 06:00AM  
Dec-23-21 10:04AM  
Dec-19-21 06:38AM  
Dec-18-21 09:38PM  
Dec-17-21 09:04AM  
Dec-13-21 11:30AM  
Dec-09-21 09:12AM  
Dec-08-21 09:09PM  
05:38PM  
11:30AM  
Dec-07-21 02:33PM  
07:56AM  
Dec-03-21 09:46AM  
Dec-02-21 11:31AM  
05:38AM  
03:00AM  
Dec-01-21 05:05PM  
03:23PM  
05:35AM  
Nov-30-21 03:18PM  
Nov-29-21 06:44AM  
Nov-25-21 09:43AM  
Nov-24-21 11:18AM  
06:50AM  
Nov-23-21 11:03AM  
09:08AM  
Nov-22-21 11:13AM  
Nov-18-21 08:30AM  
Nov-16-21 06:38AM  
Nov-04-21 08:14AM  
Nov-03-21 09:37AM  
06:24AM  
12:31AM  
Nov-02-21 06:25PM  
04:05PM  
Nov-01-21 06:00AM  
Oct-29-21 08:40AM  
Oct-26-21 03:02PM  
Oct-25-21 05:33PM  
Oct-21-21 09:25AM  
Oct-19-21 09:25AM  
Oct-12-21 12:03PM  
Oct-08-21 06:00AM  
Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for breast, prostate, and colon cancers; Oncotype MAP, a tissue test delivering tumor profiling to aid therapy selection for patients with advanced, metastatic, refractory, or recurrent cancer; Oncotype DX AR-V7 Nucleus Detect Test, a liquid-based test for advanced stage prostate cancer; and Covid-19 testing services. The company's pipeline products focus on enhancing the Cologuard test's performance characteristics and developing blood and other fluid-based tests. It has license agreements with MAYO Foundation for Medical Education and Research; and Hologic, Inc. Exact Sciences Corporation was incorporated in 1995 and is headquartered in Madison, Wisconsin.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Doyle James EdwardDirectorMar 17Option Exercise16.5210,000165,20039,830Mar 18 04:24 PM
Conroy Kevin TPresident and CEOMar 17Option Exercise6.38236,6221,509,5691,167,606Mar 18 04:22 PM
Elliott Jeffrey ThomasChief Financial OfficerMar 01Sale76.694,050310,59419,128Mar 02 05:22 PM
COWARD D SCOTTChief Legal OfficerMar 01Sale76.693,912300,01116,234Mar 02 05:25 PM
Conroy Kevin TPresident and CEOMar 01Sale76.6914,2991,096,590930,984Mar 02 05:28 PM
Condella SarahEVP, Human ResourcesMar 01Sale76.692,816215,95985,762Mar 02 05:31 PM
Condella SarahEVP, Human ResourcesFeb 28Option Exercise0.005,881088,578Mar 02 05:31 PM
Conroy Kevin TPresident and CEOFeb 28Option Exercise0.0029,8870945,283Mar 02 05:28 PM
COWARD D SCOTTChief Legal OfficerFeb 28Option Exercise0.008,288020,146Mar 02 05:25 PM
Elliott Jeffrey ThomasChief Financial OfficerFeb 28Option Exercise0.008,462023,178Mar 02 05:22 PM
ORVILLE JACOB AGeneral Manager, New VenturesFeb 24Sale70.104,717330,66215,037Feb 25 06:31 PM
COWARD D SCOTTChief Administrative OfficerFeb 24Sale70.105,815407,63111,858Feb 25 06:37 PM
Condella SarahSVP, Human ResourcesFeb 24Sale70.104,717330,66288,177Feb 25 06:43 PM
Elliott Jeffrey ThomasChief Financial OfficerFeb 24Sale70.105,897413,38014,716Feb 25 06:33 PM
Conroy Kevin TPresident and CEOFeb 24Sale70.1027,1261,901,533915,396Feb 25 06:40 PM
Conroy Kevin TPresident and CEOFeb 23Option Exercise0.0058,6430942,522Feb 25 06:40 PM
Elliott Jeffrey ThomasChief Financial OfficerFeb 23Option Exercise0.0012,747020,613Feb 25 06:33 PM
Condella SarahSVP, Human ResourcesFeb 23Option Exercise0.0010,197092,894Feb 25 06:43 PM
COWARD D SCOTTChief Administrative OfficerFeb 23Option Exercise0.0012,747017,673Feb 25 06:37 PM
ORVILLE JACOB AGeneral Manager, New VenturesFeb 23Option Exercise0.0010,197019,754Feb 25 06:31 PM
Elliott Jeffrey ThomasChief Financial OfficerFeb 23Sale69.051,557107,5117,866Feb 24 07:20 PM
COWARD D SCOTTChief Administrative OfficerFeb 23Sale69.051,10976,5764,926Feb 24 07:07 PM
ORVILLE JACOB AGeneral Manager, New VenturesFeb 23Sale69.051,12577,6819,557Feb 24 07:10 PM
Conroy Kevin TPresident and CEOFeb 23Sale69.055,188358,231883,879Feb 24 07:14 PM
Condella SarahSVP, Human ResourcesFeb 23Sale69.051,12477,61282,697Feb 24 07:16 PM
Condella SarahSVP, Human ResourcesFeb 22Option Exercise0.002,247083,821Feb 24 07:16 PM
Conroy Kevin TPresident and CEOFeb 22Option Exercise0.0010,3730889,067Feb 24 07:14 PM
ORVILLE JACOB AGeneral Manager, New VenturesFeb 22Option Exercise0.002,247010,682Feb 24 07:10 PM
COWARD D SCOTTChief Administrative OfficerFeb 22Option Exercise0.002,24706,035Feb 24 07:07 PM
Elliott Jeffrey ThomasChief Financial OfficerFeb 22Option Exercise0.003,11209,423Feb 24 07:20 PM
ORVILLE JACOB AGeneral Manager, New VenturesFeb 22Sale72.721,749127,1878,435Feb 23 05:13 PM
ORVILLE JACOB AGeneral Manager, New VenturesFeb 18Option Exercise74.133,649270,50010,184Feb 23 05:13 PM
Elliott Jeffrey ThomasChief Financial OfficerFeb 15Sale79.551,839146,2926,311Feb 16 08:14 PM
Condella SarahSVP, Human ResourcesFeb 15Sale79.5593874,61881,574Feb 16 08:17 PM
COWARD D SCOTTChief Administrative OfficerFeb 15Sale79.551,813144,2243,788Feb 16 07:58 PM
ORVILLE JACOB AGeneral Manager, New VenturesFeb 15Sale79.5594074,7776,535Feb 16 08:01 PM
Conroy Kevin TPresident and CEOFeb 15Sale79.5514,4091,146,236878,694Feb 16 08:08 PM
Conroy Kevin TPresident and CEOFeb 14Option Exercise19.53222,3164,342,004893,103Feb 16 08:08 PM
ORVILLE JACOB AGeneral Manager, New VenturesFeb 14Option Exercise78.332,030159,0107,475Feb 16 08:01 PM
COWARD D SCOTTChief Administrative OfficerFeb 14Option Exercise78.333,972311,1275,601Feb 16 07:58 PM
Condella SarahSVP, Human ResourcesFeb 14Option Exercise78.332,030159,01082,512Feb 16 08:17 PM
Elliott Jeffrey ThomasChief Financial OfficerFeb 14Option Exercise78.333,972311,1278,150Feb 16 08:14 PM
Conroy Kevin TPresident and CEONov 01Sale93.8816,9221,588,637664,380Nov 03 05:01 PM
Conroy Kevin TPresident and CEOOct 01Sale93.6417,0781,599,184681,302Oct 05 05:26 PM
Conroy Kevin TPresident and CEOSep 01Sale104.4218,9781,981,683698,380Sep 03 04:05 PM
Conroy Kevin TPresident and CEOAug 02Sale107.5019,9702,146,775717,358Aug 04 04:36 PM
Zanotti Katherine SDirectorJul 30Sale111.111,381153,43934,741Aug 02 04:44 PM
Doyle James EdwardDirectorJul 30Sale111.172,640293,48929,830Aug 02 04:42 PM
Elliott Jeffrey ThomasChief Financial OfficerJul 29Sale111.4038,3614,273,530206Aug 02 04:46 PM
Conroy Kevin TPresident and CEOJul 01Sale123.437,784960,779737,328Jul 06 04:01 PM
Condella SarahSVP, Human ResourcesJun 11Option Exercise15.2613,102199,96983,982Jun 14 04:18 PM
Condella SarahSVP, Human ResourcesJun 10Option Exercise5.031,9509,80872,830Jun 11 07:11 PM
Condella SarahSVP, Human ResourcesJun 10Sale120.005,450654,00070,880Jun 11 07:11 PM
Conroy Kevin TPresident and CEOJun 01Sale111.0012,3841,374,624745,112Jun 03 04:11 PM